EyePoint Pharmaceuticals Vs. Arvinas Industry Stock Comparison

Buy

64

EYPT
EyePoint Pharmaceuticals

Last Price:

8.92

Seasonality Move:

-14.68%

Sell

42

ARVN
Arvinas

Last Price:

25.66

Seasonality Move:

42.69%

Buy

64

EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

The current EyePoint Pharmaceuticals [EYPT] share price is $8.92. The Score for EYPT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

42

Arvinas (ARVN) is a Sell

Is Arvinas a Buy, Sell or Hold?

The current Arvinas [ARVN] share price is $25.63. The Score for ARVN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
ARVN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

The EyePoint Pharmaceuticals share price today is $8.92
The current trend is relatively stagnant and EYPT is experiencing slight buying pressure.

ARVN Stock Price Chart

What is Arvinas's stock price today?

The Arvinas share price today is $25.63
The current trend is relatively stagnant and ARVN is experiencing buying pressure, which is a positive indicator for future bullish movement.

EYPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.05	Buy
Relative Strength Index (14 RSI):	52.77	Buy
Chaikin Money Flow:	19446	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(8.13 - 9.09)	Buy
Bollinger Bands (100):	(7.58 - 12.06)	Sell

ARVN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.17	Sell
Relative Strength Index (14 RSI):	51.33	Buy
Chaikin Money Flow:	704407	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(24.76 - 25.9)	Buy
Bollinger Bands (100):	(24.52 - 31.18)	Sell

EYPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	8.85	Buy
20-day SMA:	8.69	Buy
50-day SMA:	8.88	Buy
200-day SMA:	16.38	Sell
8-day EMA:	8.84	Buy
20-day EMA:	8.71	Buy
50-day EMA:	9.07	Sell
200-day EMA:	12.31	Sell

ARVN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	25.14	Buy
20-day SMA:	25.42	Buy
50-day SMA:	26.36	Sell
200-day SMA:	34.22	Sell
8-day EMA:	25.3	Buy
20-day EMA:	25.34	Buy
50-day EMA:	26.17	Sell
200-day EMA:	30.07	Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.

Arvinas Earnings Growth & ARVN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.65 per share, an increase this year of $1.66 per share, and a decrease next year of $1.40 per share.

EyePoint Pharmaceuticals Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arvinas Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):